Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.

Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Abstract Text:

Yasuhiro Miyake,Yoshiaki Iwasaki,Akinobu Takaki,Haruhiko Kobashi,Kohsaku Sakaguchi,Yasushi Shiratori,Yasuhiro Miyake,Yoshiaki Iwasaki,Akinobu Takaki,Haruhiko Kobashi,Kohsaku Sakaguchi,Yasushi Shiratori,Yasuhiro Miyake,Yoshiaki Iwasaki,Akinobu Takaki,Haruhiko Kobashi,Kohsaku Sakaguchi,Yasushi Shiratori,

Objective In Caucasian type 1 autoimmune hepatitis patients with a main susceptibility of human leukocyte antigen DR3 and DR4, elderly patients have a higher frequency of concurrent autoimmune disease and cirrhosis at presentation. However, in Japanese patients, the disease is dominantly associated with DR4, and their clinical features may be different from those of previous reports. In this study, we assessed the clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Methods We investigated 160 consecutive patients with type 1 autoimmune hepatitis, consisting of 34 elderly patients (>/=65 years) and 126 younger patients (<65 years). Results There were no differences in form of clinical onset, frequencies of concurrent autoimmune disease, positive proportions of anti-nuclear antibody and/or anti-smooth muscle antibody, and human leukocyte antigen DR status between the two groups. However, the elderly patients had lower serum levels of albumin (p=0.0049), and higher frequencies of cirrhosis (F4) and pre-cirrhosis (F3) (p=0.014) compared with the younger patients. In contrast, in elderly patients, the cumulative incidental rate of the normalization of serum alanine aminotransferase levels within 6 months after the introduction of initial treatment was higher in those treated with prednisolone >/=20 mg/day than those treated only with ursodeoxycholic acid (p=0.001). Conclusion We speculate that more years may pass between the occurrence of the disease and the presentation in Japanese elderly patients than in younger patients, and we considered that, even in elderly patients, those with advanced fibrosis should be treated with prednisolone in order to prevent progress of the disease into liver failure.

Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Publishing Authors By Initials

Y Miyake,Y Iwasaki,A Takaki,H Kobashi,K Sakaguchi,Y Shiratori,Y Miyake,Y Iwasaki,A Takaki,H Kobashi,K Sakaguchi,Y Shiratori,Y Miyake,Y Iwasaki,A Takaki,H Kobashi,K Sakaguchi,Y Shiratori,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Internal medicine (Tokyo, Japan)

VOLUME: 46

Page Numbers: 1945-50

Journal Abbreviation: Intern. Med.

ISSN: 1349-7235

DAY: 17

MONTH: 12

YEAR: 2007

Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9204241

Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.

AFFILIATION: Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.

Country: Japan

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Intern Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis Related Publications

• A layered mesoporous carbon sensor based on nanopore-filling cooperative adsorption in the liquid phase.
• A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis.
• A possible role of histone-like DNA-binding protein of Streptococcus intermedius in the pathogenesis of bile duct damage in primary biliary cirrhosis.
• An analysis of risk factors for asymptomatic cerebral infarction.
• Anticipatory postural adjustments while sitting: the effects of different leg supports.
• Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.
• Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis.
• Combined pantethine and probucol therapy for Japanese patients with non-alcoholic steatohepatitis.
• Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
• Decreased expression of hMLH1 correlates with reduced 5-fluorouracil-mediated apoptosis in colon cancer cells.
• Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology.
• Dynamic induction of ADAMTS1 gene in the early phase of acute myocardial infarction.
• Engulfment of necrotic acinar cells by pancreatic stellate cells inhibits pancreatic fibrogenesis.
• Familial aggregation in patients with non-alcoholic steatohepatitis.
• Fibrosis progression rates between chronic hepatitis B and C patients with elevated alanine aminotransferase levels.
• Gastrointestinal: Angioedema of the small bowel.
• Gastrointestinal: Phlebosclerotic colitis.
• Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features.
• Human leukocyte antigen DR status and clinical features in Japanese patients with type 1 autoimmune hepatitis.
• Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis.
• Intrahepatic biliary epithelial cell damage and inflammation in portal tract in association with chronic colitis-harboring TCRalpha(-/-) mice.
• Lamivudine treatment improves the prognosis of fulminant hepatitis B.
• Long-term follow up of esophageal varices after balloon-occluded retrograde transvenous obliteration for gastric varices.
• Prevalence of esophagogastric varices in patients with non-alcoholic steatohepatitis.
• Risk factors and indications for first surgery in Crohn's disease patients.
• Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
• Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas.
• THE FORMATION OF CHOLESTEROL ESTERS WITH RAT LIVER ENZYMES.
• The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease.
• [Clinical features of esophago-gastric varices caused by pancreatic cancer]